《大行報告》麥格理下調華晨(01114.HK)目標價10.1元評級「跑贏大市」
麥格理發表研究報告,指在華晨(01114.HK)業績簡布會後,更有信心期望公司可在2022年之前可派更多中期股息,意味2020/2021年股息回報率達7%,並有上升潛力。
基本面方面,公司預期華晨寶馬合營未來數年將繼續跑贏中國汽車市場,成為替換需求上升的主要受益者。此外,該行認為寶馬有潛力將華晨寶馬定位為其環球新能源汽車計劃的其中一個中心。
麥格理維持華晨「跑贏大市」評級,並指該股為行業首選;該行又將公司2019-2020年每股盈利預測下調4%,目標價由10.3元降至10.1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.